Evidence map›Paper›PMID 37377871›Full record

ArticleRSC advances2023

Melamine-isatin tris Schiff base as an efficient corrosion inhibitor for mild steel in 0.5 molar hydrochloric acid solution: weight loss, electrochemical and surface studies.

Ifzan Arshad, Khizar Qureshi, Awais Siddique Saleemi, Ali Abdullah, Aboud Ahmed Awadh Bahajjaj, Shafaqat Ali, Awais Bokhari

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Ifzan ArshadDepartment of Chemistry, University of Management and Technology Sialkot Pakistan mifzan@gmail.com arshadmi@mail.ustc.edu.cn.ORCID https://orcid.org/0000-0003-2164-6911
Khizar QureshiDepartment of Chemistry, University of Management and Technology Sialkot Pakistan mifzan@gmail.com arshadmi@mail.ustc.edu.cn.ORCID https://orcid.org/0000-0003-3437-3174
Awais Siddique SaleemiNano & Micro FT Laboratory, Program of Physics, University of Management and Technology Sialkot Campus Sialkot 51310 Pakistan.
Ali AbdullahNano & Micro FT Laboratory, Program of Physics, University of Management and Technology Sialkot Campus Sialkot 51310 Pakistan.
Aboud Ahmed Awadh BahajjajDepartment of Chemistry, College of Science, King Saud University Riyadh 11451 Saudi Arabia.ORCID https://orcid.org/0000-0003-0134-9039
Shafaqat AliDepartment of Environmental Science, Government College University Faisalabad Faisalabad 38000 Punjab Pakistan.
Awais BokhariSustainable Process Integration Laboratory, Faculty of Mechanical Engineering, Brno University of Technology 2896/2 61600 Brno Czech Republic.
University of Management and Technology · PKBrno University of Technology · CZChina Medical University · TWKing Saud University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the current study, 3,3',3''-((1,3,5-triazine-2,4,6-triyl)tris(azaneylylidene))tris(indolin-2-one) (MISB), which is the condensation product of melamine (triazine) and isatin, was investigated as a mild steel corrosion inhibitor in 0.5 M HCl. The ability of the synthesized tris-Schiff base to suppress corrosion was evaluated utilizing weight loss measurements, electrochemical techniques and theoretical computation. The maximum inhibition efficiency of 92.07%, 91.51% and 91.60% was achieved using 34.20 × 10

Identifiers

PMID37377871
PMCPMC10291281
OpenAlexW4382135997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.